Repare Therapeutics (RPTX) Competitors $1.20 +0.05 (+4.35%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$1.20 +0.01 (+0.42%) As of 04/17/2025 06:24 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RPTX vs. MDWD, IVA, GNFT, RZLT, ACIU, HURA, DBVT, NBTX, DMAC, and CGCShould you be buying Repare Therapeutics stock or one of its competitors? The main competitors of Repare Therapeutics include MediWound (MDWD), Inventiva (IVA), Genfit (GNFT), Rezolute (RZLT), AC Immune (ACIU), TuHURA Biosciences (HURA), DBV Technologies (DBVT), Nanobiotix (NBTX), DiaMedica Therapeutics (DMAC), and Canopy Growth (CGC). These companies are all part of the "pharmaceutical products" industry. Repare Therapeutics vs. MediWound Inventiva Genfit Rezolute AC Immune TuHURA Biosciences DBV Technologies Nanobiotix DiaMedica Therapeutics Canopy Growth Repare Therapeutics (NASDAQ:RPTX) and MediWound (NASDAQ:MDWD) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, community ranking, media sentiment, institutional ownership, profitability and dividends. Which has more risk & volatility, RPTX or MDWD? Repare Therapeutics has a beta of 0.91, indicating that its share price is 9% less volatile than the S&P 500. Comparatively, MediWound has a beta of 0.5, indicating that its share price is 50% less volatile than the S&P 500. Does the MarketBeat Community prefer RPTX or MDWD? MediWound received 354 more outperform votes than Repare Therapeutics when rated by MarketBeat users. However, 64.18% of users gave Repare Therapeutics an outperform vote while only 62.23% of users gave MediWound an outperform vote. CompanyUnderperformOutperformRepare TherapeuticsOutperform Votes4364.18% Underperform Votes2435.82% MediWoundOutperform Votes39762.23% Underperform Votes24137.77% Do institutionals & insiders have more ownership in RPTX or MDWD? 85.1% of Repare Therapeutics shares are owned by institutional investors. Comparatively, 46.8% of MediWound shares are owned by institutional investors. 21.6% of Repare Therapeutics shares are owned by insiders. Comparatively, 9.2% of MediWound shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Is RPTX or MDWD more profitable? Repare Therapeutics has a net margin of -99.76% compared to MediWound's net margin of -142.29%. Repare Therapeutics' return on equity of -40.87% beat MediWound's return on equity.Company Net Margins Return on Equity Return on Assets Repare Therapeutics-99.76% -40.87% -35.07% MediWound -142.29%-82.17%-33.67% Which has better earnings and valuation, RPTX or MDWD? MediWound has lower revenue, but higher earnings than Repare Therapeutics. MediWound is trading at a lower price-to-earnings ratio than Repare Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRepare Therapeutics$53.48M0.95-$93.80M-$2.00-0.60MediWound$20.22M9.14-$6.72M-$3.07-5.57 Do analysts recommend RPTX or MDWD? Repare Therapeutics currently has a consensus target price of $4.50, indicating a potential upside of 275.00%. MediWound has a consensus target price of $31.33, indicating a potential upside of 83.24%. Given Repare Therapeutics' higher possible upside, research analysts clearly believe Repare Therapeutics is more favorable than MediWound.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Repare Therapeutics 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50MediWound 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media refer more to RPTX or MDWD? In the previous week, Repare Therapeutics and Repare Therapeutics both had 2 articles in the media. Repare Therapeutics' average media sentiment score of 0.50 beat MediWound's score of 0.34 indicating that Repare Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Repare Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive MediWound 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryRepare Therapeutics beats MediWound on 11 of the 17 factors compared between the two stocks. Get Repare Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RPTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RPTX vs. The Competition Export to ExcelMetricRepare TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$51.01M$6.46B$5.31B$7.35BDividend YieldN/A3.22%5.47%4.31%P/E Ratio-0.606.9521.9417.82Price / Sales0.95231.01380.9497.70Price / CashN/A65.6738.3134.64Price / Book0.245.936.453.98Net Income-$93.80M$143.22M$3.22B$247.81M7 Day Performance33.33%4.28%5.85%3.19%1 Month Performance7.14%-13.11%-9.58%-7.70%1 Year Performance-61.90%-8.51%11.85%1.49% Repare Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RPTXRepare Therapeutics3.1087 of 5 stars$1.20+4.3%$4.50+275.0%-61.9%$51.01M$53.48M-0.60180Short Interest ↓Gap DownHigh Trading VolumeMDWDMediWound1.2281 of 5 stars$15.08+0.7%$31.33+107.8%+8.4%$162.76M$20.22M-5.2080IVAInventiva1.6517 of 5 stars$3.10+1.0%$12.00+287.1%+1.2%$162.68M$9.20M0.00100Gap DownGNFTGenfit1.149 of 5 stars$3.25-3.4%$13.00+300.6%+2.2%$162.24M$76.06M0.00120Upcoming EarningsPositive NewsRZLTRezolute2.9209 of 5 stars$2.64+4.3%$24.38+823.3%-19.8%$159.81MN/A-2.1640News CoveragePositive NewsGap DownACIUAC Immune2.5072 of 5 stars$1.59-4.2%$12.00+654.7%-37.3%$159.65M$27.31M-3.46140Analyst RevisionNews CoverageGap DownHURATuHURA BiosciencesN/A$3.64+7.7%$12.67+248.0%N/A$159.00MN/A0.00N/AAnalyst RevisionNews CoverageGap DownDBVTDBV Technologies2.6185 of 5 stars$7.44+14.5%$22.50+202.4%+17.1%$153.03M$15.73M-1.6580Earnings ReportAnalyst ForecastShort Interest ↑NBTXNanobiotix1.7973 of 5 stars$3.17-3.1%$8.00+152.4%-38.3%$149.41M$36.22M0.00100DMACDiaMedica Therapeutics1.2274 of 5 stars$3.48-0.6%$8.00+129.9%+48.1%$149.14MN/A-6.2120Short Interest ↑News CoverageGap DownCGCCanopy Growth2.2583 of 5 stars$0.93+1.1%$2.00+114.9%-85.0%$147.59M$276.75M-0.243,150Options VolumeNews Coverage Related Companies and Tools Related Companies MediWound Alternatives Inventiva Alternatives Genfit Alternatives Rezolute Alternatives AC Immune Alternatives TuHURA Biosciences Alternatives DBV Technologies Alternatives Nanobiotix Alternatives DiaMedica Therapeutics Alternatives Canopy Growth Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RPTX) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Repare Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Repare Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RPTX Stock Free RPTX Stock Alerts